• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza increases invasive meningococcal disease risk in temperate countries

tetano

Editor, Senior Moderator
[h=1]Clin Microbiol Infect. 2020 Jan 11. pii: S1198-743X(20)30026-4. doi: 10.1016/j.cmi.2020.01.004. [Epub ahead of print][/h] [h=1]Influenza increases invasive meningococcal disease risk in temperate countries.[/h]
Salomon A[SUP]1[/SUP], Berry I[SUP]1[/SUP], Tuite AR[SUP]1[/SUP], Drews S[SUP]2[/SUP], Hatchette T[SUP]3[/SUP], Jamieson F[SUP]4[/SUP], Johnson C[SUP]5[/SUP], Kwong J[SUP]1[/SUP], Lina B[SUP]6[/SUP], Lojo J[SUP]5[/SUP], Mosnier A[SUP]7[/SUP], Ng V[SUP]8[/SUP], Vanhems P[SUP]9[/SUP], Fisman DN[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]OBJECTIVES:[/h] Invasive meningococcal disease (IMD) is a severe bacterial infection that displays wintertime seasonality in temperate countries. Mechanisms driving seasonality are poorly understood and may include environmental conditions and/or respiratory virus infections. We evaluated the contribution of influenza and environmental conditions to IMD risk, using standardized methodology, across multiple geographical regions.
[h=4]METHODS:[/h] We evaluated 3,276 IMD cases occurring between January 1999 and December 2011 in 11 jurisdictions in Australia, Canada, France and The United States. Effects of environmental exposures, and normalized weekly influenza activity, on IMD risk were evaluated using a case-crossover design. Meta-analytic methods were used to evaluate homogeneity of effects and to identify sources of between-region heterogeneity.
[h=4]RESULTS:[/h] After adjustment for environmental factors, elevated influenza activity at a two-week lag was associated with increased IMD risk (adjusted OR per standard deviation increase 1.29, 95% CI: 1.04-1.59). This increase was homogeneous across jurisdictions studied. By contrast, although associations between environmental exposures and IMD were identified in individual jurisdictions, none were generalizable.
[h=4]CONCLUSIONS:[/h] Using a self-matched design that adjusts for both co-seasonality and case characteristics, we find that surges in influenza activity result in an acute increase in population-level IMD risk. This effect is seen across diverse geographic regions in North America, France, and Australia. The impact of influenza infection on downstream meningococcal risk should be considered a potential benefit of influenza immunization programs.
Crown Copyright ? 2020. Published by Elsevier Ltd. All rights reserved.


[h=4]KEYWORDS:[/h] Australia; Canada; France; Neisseria meningitidis; United States; case-crossover; epidemiology; influenza; invasive meningococcal disease; meningitis; seasonality

PMID: 31935565 DOI: 10.1016/j.cmi.2020.01.004

[h=1][/h]
 
Back
Top Bottom